Nurix Therapeutics, Inc. Common stock (NRIX) is a publicly traded Healthcare sector company. As of July 5, 2026, NRIX trades at $23.97 with a market cap of $2.48B and a P/E ratio of -7.56. NRIX moved +0.33% today. Year to date, NRIX is +26.03%; over the trailing twelve months it is +92.68%. Its 52-week range spans $8.18 to $29.56. Analyst consensus is strong buy with an average price target of $33.00. Rallies surfaces NRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NRIX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $23.97 |
| Market Cap | $2.48B |
| P/E Ratio | -7.56 |
| EPS | $-3.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.56 |
| 52-Week Low | $8.18 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $71.78M |
| Net Income | $-295.28M |
| Gross Margin | 0.00% |
12 analysts cover NRIX: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $33.00.